1. Atherothrombotic residual risk in coronary and peripheral artery disease patients on guideline-recommended antiplatelet monotherapy: baseline preliminary results from the RESRISK study. (14th October 2021) Authors: Vallejo-Vaz, A; Dharmayat, K I; Nzeakor, N; Fatoba, S T; McMahon, P; Tolani, E; Carrasco, C P; Ray, K K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗